pharmacy practice, policy and regulations
Quiz yourself by thinking what should be in
each of the black spaces below before clicking
on it to display the answer.
Help!
|
|
||||
---|---|---|---|---|---|
show | amount of a drug that will produce an effect in 50% of animals tested
🗑
|
||||
LD 50 | show 🗑
|
||||
show | voluntary reporting of ADEs, product quality concerns etc. for health care professionals. and ok to disclose PHI for public health purposes
🗑
|
||||
Medwatch form FDA 3500A | show 🗑
|
||||
show | like 3500 but specifically for consumer reporting.
🗑
|
||||
show | PHARMACEUTICAL COMPOUNDING FOR NONSTERILE PREPARATIONS
🗑
|
||||
USP 797 | show 🗑
|
||||
CSPs | show 🗑
|
||||
beyond use dating | show 🗑
|
||||
show | the assigned beyond use date based on the maximum chemical stability as listed in valid references.
🗑
|
||||
show | room temperature = 48 hours
fridge = 14 days
freezer = 45 days
🗑
|
||||
show | room temperature = 30 hours
fridge = 7 days
freezer = 45 days
🗑
|
||||
beyond use dating for high risk compounded sterile products without sterility testing. room temp/refrigeration/freezer | show 🗑
|
||||
show | Low-risk: using sterile transfer of sterile liquids from manufacturer-sealed containers to sterile devices or other sterile packages. It also covers manually mixing and measuring up to three manufactured products to create a CSP or nutritional solution.
🗑
|
||||
medium risk according to USP 797 | show 🗑
|
||||
show | non-sterile ingredients/devices. Exposing sterile items below ISO Class 5. prolonged storage of opened or partially-used products that lack antimicrobial preservatives. solution that will be terminally sterilized from non-sterile bulk drug or device.
🗑
|
||||
when should the investigational new drug application be submitted to the FDA | show 🗑
|
||||
show | lab and animal studies assessing safety and biological activity. establishes ED50 and LD 50 and toxicology and preggers category B, C and some D.
🗑
|
||||
show | first study in human subjects. must have INDA approved by FDA prior to starting. starts with healthy volunteers. PK and PD properties are established
🗑
|
||||
show | controlled studies in a small (several hundred) group of subjects that evaluates effectiveness for specific indication in pts with the disease under investigation. determines short term ADEs and risks
🗑
|
||||
WHat constitutes a phase III trial | show 🗑
|
||||
show | post marketing studies. verifies effectiveness or focus treatment on special populations. the FDA can require this of manufacturers to help identify additional risks not identified in Phase III trials
🗑
|
||||
what is 45 Code of Federal Regulations part 46 | show 🗑
|
||||
show | HIPAA
🗑
|
||||
Hatch Watchman Act 1984 | show 🗑
|
||||
show | drugs must demonstrate efficacy AND safety. requires informed consent of study subjects. authorizes FDA to regulate drug advertising and establish good manufacturing practices
🗑
|
||||
show | amendment to the food and drug act to differentiate between prescription and non prescription drugs
🗑
|
||||
show | clinical trials.gov. exclusive provisions for pediatric drugs. streamlines research on drugs and devies
🗑
|
||||
PDUFA prescription drug user fee act of 1992 | show 🗑
|
||||
show | cost minimization analysis, cost benefit analysis, cost effectiveness analysis, cost utility analysis
🗑
|
||||
partial economic evaluations | show 🗑
|
||||
direct health care costs | show 🗑
|
||||
indirect health care costs | show 🗑
|
||||
show | pain, suffering, inconvenience, grief. not usually formally quantified. may use QALYs to measure.
🗑
|
||||
show | looking at two clinical outcomes, evaluate the value of the difference in cost
🗑
|
||||
cost benefit analysis | show 🗑
|
||||
cost utility analysis | show 🗑
|
||||
cost of illness | show 🗑
|
||||
show | cost per treatment alternative. determines least costly alternative. compares two or more treatment alternatives with demonstrated equivalence in therapeutic outcomes.
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
mjuhlin
Popular Pharmacology sets